Noushin Niknafs
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 16
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- Pancreatic and Hepatic Oncology Research 3
-
- Genomics and Phylogenetic Studies 5
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
-
- Immunotherapy and Immune Responses 4
- Pharmacology top 10%
-
- Genomics and Rare Diseases 4
- Co-authors
- Rachel KarchinValsamo AnagnostouVictor E. VelculescuChristopher DouvilleRick KimPeter D. StensonD.N. CooperPhuoc T. Tran
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Noushin Niknafs
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 389
- Oncology 341
- Molecular Biology 598
- Immunology 163
- Pharmacology 65
Countries citing papers authored by Noushin Niknafs
This map shows the geographic impact of Noushin Niknafs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noushin Niknafs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noushin Niknafs more than expected).
Fields of papers citing papers by Noushin Niknafs
This network shows the impact of papers produced by Noushin Niknafs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noushin Niknafs. The network helps show where Noushin Niknafs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noushin Niknafs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 24 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 66 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 11 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 67 | |
| 13 | 2017 | 340 | |
| 14 | 2016 | 68 | |
| 15 | 2016 | 71 | |
| 16 | 2015 | 35 | |
| 17 | 2014 | 40 | |
| 18 | 2013 | 17 | |
| 19 | 2013 | 41 | |
| 20 | 2013 | 199 |
About Noushin Niknafs
Noushin Niknafs is a scholar working on Cancer Research, Oncology and Immunology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (16 papers), Cancer Immunotherapy and Biomarkers (10 papers), Genomics and Phylogenetic Studies (5 papers), Genomics and Rare Diseases (4 papers), Immunotherapy and Immune Responses (4 papers), Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (389 citations), Oncology (341 citations) and Molecular Biology (598 citations). Noushin Niknafs has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Rachel Karchin, Valsamo Anagnostou, Victor E. Velculescu, Christopher Douville, Rick Kim, Peter D. Stenson, D.N. Cooper, Phuoc T. Tran, Matthew D. Hellmann and Meredith L. Stone. Their work appears in journals such as Cell, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.